Managing Director & Partner
Paul-Alexis Kebabtchieff (PAK) is a core member of Boston Consulting Group’s Health Care practice and a member of the biopharma leadership team. He is the global lead for the firm’s medical client work, part of the commercial biopharma leadership team, and a North America leader for commercial transformation.
PAK works almost exclusively with health care biopharma clients at BCG, with a focus on biopharma/biotech strategy, from early-stage assets to loss of exclusivity, transformation, and operations projects. He is one of the co-leads of the BCG Medical Roundtable.
As an expert in biopharma strategy and operations, including commercialization, medical affairs, and value and access, PAK has extensive experience in multiple treatment and disease categories including oncology, hematology, inflammation, immunology, and cardiovascular diseases. He also has deep expertise in cell and gene therapy and rare diseases. Prior to joining BCG, PAK worked at L’Oréal (Strategic Marketing, Paris) and PwC (Strategy Group, London).
To advance from promise to value, biopharma companies need to articulate and execute a bold vision for analytics as a fully scaled, continuously applied internal capability.